Cellular integrity is required for inhibition of initiation of cellular DNA synthesis by reovirus type 3.
Synchronized HeLa cells, primed for entry into the synthesis phase by amethopterin, were prevented from initiating DNA synthesis 9 h after infection with reovirus type 3. However, nuclei isolated from synchronized cells infected with reovirus for 9 or 16 h demonstrated a restored ability to synthesize DNA. The addition of enucleated cytoplasmic extracts from infected or uninfected cells did not affect this restored capacity for synthesis. The addition of ribonucleotide triphosphates to nuclei isolated from infected cells stimulated additional DNA synthesis, suggesting that these nuclei were competent to initiate new rounds of DNA replication. Permeabilization of infected cells did not restore the ability of these cells to synthesize DNA. Nucleoids isolated from intact or permeabilized cells, infected for 9 or 16 h displayed an increased rate of sedimentation when compared with nucleoids isolated from uninfected cells. Nucleoids isolated from the nuclei of infected cells demonstrated a rate of sedimentation similar to that of nucleoids isolated from the nuclei of uninfected cells. The inhibition of initiation of cellular DNA synthesis by reovirus type 3 appears not to have been due to a permanent alteration of the replication complex, but this inhibition could be reversed by the removal of that complex from factors unique to the structural or metabolic integrity of the infected cell.
D000956:Antigens, Viral / Q000032:analysis; D002458:Cell Fractionation; D002463:Cell Membrane Permeability; D002467:Cell Nucleus / Q000378:metabolism*; D002499:Centrifugation, Density Gradient; D003593:Cytoplasm / Q000502:physiology; D004247:DNA / Q000096:biosynthesis*; D006367:HeLa Cells; D006801:Humans; D007399:Interphase / Q000187:drug effects; D012089:Mammalian orthoreovirus 3 / Q000032:analysis / Q000187:drug effects / Q000502:physiology*; D008727:Methotrexate / Q000494:pharmacology; D012087:Reoviridae / Q000502:physiology*; D012265:Ribonucleotides / Q000494:pharmacology; D014779:Virus Replication / Q000187:drug effects
D000956:Antigens, Viral; D012265:Ribonucleotides; D004247:DNA; D008727:Methotrexate